story of the week
cTnI and cTnT and NT-proBNP for Monitoring Cardiac Safety of Patients With Early-Stage HER2-Positive Breast Cancer Taking Trastuzumab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology